Vanguard Group Inc Catalent, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 20,232,750 shares of CTLT stock, worth $1.2 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,232,750

Previous 20,391,078 0.78%

Holding current value

$1.2 Billion

Previous $1.15 Billion 6.88%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $8.89 Million - $9.65 Million	-158,328 Reduced 0.78%	20,232,750 $1.23 Billion
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $755,638 - $804,153	-14,103 Reduced 0.07%	20,391,078 $1.15 Billion
Q1 2024 May 10, 2024	BUY	$42.56 - $59.82 $9.31 Million - $13.1 Million	218,682 Added 1.08%	20,405,181 $1.15 Billion
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $9.06 Million - $13.1 Million	-281,528 Reduced 1.38%	20,186,499 $907 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $16.2 Million - $18.4 Million	365,648 Added 1.82%	20,468,027 $932 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $12.3 Million - $25.9 Million	384,630 Added 1.95%	20,102,379 $872 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $5.89 Million - $9.63 Million	129,646 Added 0.66%	19,717,749 $1.3 Billion
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $15.1 Million - $29.6 Million	364,861 Added 1.9%	19,588,103 $881 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $12.9 Million - $20.2 Million	178,443 Added 0.94%	19,223,242 $1.39 Billion
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $6.41 Million - $8.38 Million	73,457 Added 0.39%	19,044,799 $2.04 Billion
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $46.3 Million - $61.3 Million	492,071 Added 2.66%	18,971,342 $2.1 Billion
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $28.2 Million - $32.8 Million	236,025 Added 1.29%	18,479,271 $2.37 Billion
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $9.61 Million - $12.5 Million	-88,073 Reduced 0.48%	18,243,246 $2.43 Billion
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $1.84 Billion - $2.12 Billion	18,331,319 New	18,331,319 $1.98 Billion

Others Institutions Holding CTLT

# of Institutions

512

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Catalent, Inc. Transaction History